Prescription Technology Solutions — Restructuring Reserve

McKesson Prescription Technology Solutions — Restructuring Reserve decreased by 66.7% to $5.00M in Q3 2023 compared to the prior quarter. Year-over-year, this metric grew by 66.7%, from $3.00M to $5.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment

CategoryLiquidity

SignalLower is better

VolatilityModerate

First reportedQ1 2021

Last reportedQ3 2023

Rolls up toRestructuring Reserve

How to read this metric

A declining balance indicates that the company is actively executing and paying out its restructuring obligations, whereas a rising balance suggests new initiatives or delays in implementation.

Detailed definition

This metric tracks the outstanding liability balance set aside to cover future cash outflows related to previously annou...

Peer comparison

Comparable to 'restructuring accruals' or 'restructuring liabilities' found on the balance sheets or segment footnotes of peer companies.

Metric ID: mck_segment_prescription_technology_solutions_restructuring_reserve

Historical Data

10 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23
Value	$4.00M	$4.00M	$4.00M	$3.00M	$3.00M	$3.00M	$3.00M	$26.00M	$15.00M	$5.00M
QoQ Change	—	+0.0%	+0.0%	-25.0%	+0.0%	+0.0%	+0.0%	+766.7%	-42.3%	-66.7%
YoY Change	—	—	—	—	-25.0%	-25.0%	-25.0%	+766.7%	+400.0%	+66.7%

Range$3.00M – $26.00M

CAGR+10.4%

Avg YoY Growth+193.1%

Median YoY Growth+20.8%

Current Streak2 quarters decline

Similar Metrics at Other Companies

S&P GlobalSPGI View metric

Elevance HealthELV View metric

OracleORCL View metric

Frequently Asked Questions

What is McKesson's prescription technology solutions — restructuring reserve?: McKesson (MCK) reported prescription technology solutions — restructuring reserve of $5.00M in Q3 2023.
How has McKesson's prescription technology solutions — restructuring reserve changed year-over-year?: McKesson's prescription technology solutions — restructuring reserve increased by 66.7% year-over-year, from $3.00M to $5.00M.
What does prescription technology solutions — restructuring reserve mean?: The remaining liability balance reserved for future cash payments related to restructuring activities.